SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 128.55 millions for the September 2024 quarter as against Rs. 148.90 millions during the year-ago period.The Net Loss for the quarter ended September 2024 is Rs. -57.61 millions as compared to Net Loss of Rs. -35.72 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 further decreased to -26.24% as compared to -7.27% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 128.55 148.90 -13.67 257.44 254.71 1.07 504.22 521.34 -3.28
Other Income 0.86 1.74 -50.57 1.20 2.12 -43.40 4.51 6.20 -27.26
PBIDT -26.24 -7.27 260.94 -47.87 -33.09 44.67 -82.72 -151.59 -45.43
Interest 14.25 11.34 25.66 27.43 22.31 22.95 46.89 29.73 57.72
PBDT -40.49 -18.61 117.57 -75.30 -55.40 35.92 -129.61 -181.32 -28.52
Depreciation 17.12 17.11 0.06 34.02 33.64 1.13 67.66 65.59 3.16
PBT -57.61 -35.72 61.28 -109.32 -89.04 22.78 -197.27 -246.91 -20.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -57.61 -35.72 61.28 -109.32 -89.04 22.78 -197.27 -246.91 -20.10
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -20.41 -4.88 318.07 -18.59 -12.99 43.13 -16.41 -29.08 -43.58

Krebs Biochem.&Inds Share Price

60.50 -0.40 (-0.66%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×